方法白酒灌胃法建立酒精性肝病大鼠模型。
Methods The model of alcoholic hepatic disorder was established by feeding alcohol liquor.
国际肝病：核受体在胆汁淤积性肝病很重要。
Hepatology Digest: The nuclear receptors are important in cholestatic liver disease.
保护肝细胞可以有效的防止致命性肝病的发生。
So the inhibition of hepatic injury can prevent the fatal disease of liver effectively.
目的：观察甘乐对酒精性肝病的疗效和安全性。
Objective: To observe the therapeutic effects and the reliability of Canle on alcoholic liver disease (ALD).
结论美他多辛片可安全、有效地治疗酒精性肝病。
Conclusion Metadoxine is effective and safe in treatment of alcoholic liver disease.
目的：观察还原性谷胱甘肽治疗酒精性肝病的疗效。
Objective: To observe the efficacy of Glutathlone on the treatment of alcoholic liver diseases.
观察疏肝清脂汤治疗混合性肝病肝纤维化的临床疗效。
To observe the clinical effect of Sugan Qingzhi Decoction on mixed liver disease fibrosis.
肝移植提供了一个小肿瘤和相关性肝病治愈的最佳机会。
Liver transplantation offers the best chance for a cure in patients with small tumors and significant associated liver disease.
有研究表明胰岛素抵抗与非酒精性脂肪性肝病密切相关。
Insulin resistance has been shown to be associated with non-alcoholic fatty liver.
目的初步建立并评价蒙古沙鼠非酒精性脂肪性肝病模型。
Objective To establish and evaluate the animal model of nonalcoholic fatty liver disease in Mongolian gerbils.
结论长期低浓度酒精摄入可导致低龄大鼠酒精性肝病发生。
Conclusion Longterm alcohol consumption may induce alcohol liver disease in the younger rat.
此文就脂肪性肝病向原发性肝癌进展的可能机制作一综述。
This article is mainly about the possible pathogenesis how fatty liver disease progress to liver cancer.
目的寻找一种简单可靠的方法制作大鼠慢性酒精性肝病模型。
Objective To search a simple and reliable method for establishing an alcoholic liver disease model in rats.
目的观察自拟降脂汤联合硫普罗宁治疗酒精性肝病的临床疗效。
Objective To observe the clinical effect of self-composed decoction for lowering lipid combined with Tiopronine in treating alcohol liver disease.
目的：探讨川芎嗪联合谷胱甘肽对酒精性肝病的疗效及安全性。
Objective: To explore the effect and safety of tetramethylpyrazine combined glutathione on alcoholic liver disease.
目的评价胆宁片治疗非酒精性脂肪性肝病（湿热型）的临床疗效。
ObjectiveTo evaluate the therapeutic effect of Danning Tablet (DNT) on patients with non-alcoholic fatty liver (NAFL) of damp-heat Syndrome type.
结论非甲-非戊型肝炎可存在自身免疫性肝病和其他类型肝炎病毒。
Autoimmue liver disease and other hepatitis virus may be present in Non-A, Non-E hepatitis.
我们描述了例酒精性肝病患者并发严重溶血性贫血，需要多次输血。
We observed three patients with alcoholic liver disease, suffering from severe hemolytic anemia, requiring multiple blood transfusions.
目的：研究健脾补肾中药治疗非酒精性脂肪性肝病的疗效和安全性。
Objetive: To investigate the efficacy and safety of Jianpi Bushen herb in the treatment of nonalcoholic fatty liver diseases (NAFLD).
本文就双环醇在脂肪性肝病的基础研究与临床应用的进展加以综述。
This article is a review about the advance in basic and clinical research.
目的：观察疏肝降浊汤治疗非酒精性脂肪性肝病的临床疗效及安全性。
Objective: To observe the clinical effect and safety of Shugan Jiangzhuo Decoction in treating nonalcoholic fatty liver disease (NAFLD).
图像定量分析表明，酒精性肝病肝纤维化程度重于慢性病毒性肝炎者。
Image-analysis showed that the percentage of fibrous tissues was higher in ALD than that in chronic viral hepatitis at same stage of fibrosis.
这是否反映了非酒精性脂肪性肝病或肝脏的直接血糖损伤，尚无法判断。
Whether this reflects nonalcoholic fatty liver disease or direct glycemic injury of the liver remains to be determined.
目的：观察清肝活血方对酒精性肝病大鼠乙醇代谢关键酶基因表达的影响。
Objective: To observe the effect of Qinggan Huoxue Decoction on gene expression of key enzyme about alcohol metabolism of Wistar rat with alcoholic liver disease (ALD).
目的：初步验证古拉定(国产注射用还原型谷胱甘肽)对酒精性肝病的疗效。
Objective: To study the efficacy of domestic reduced glutathione vial for injection in comparison with imported Gluthion in treatment of chronic alcoholic liver disease (CALD).
方法超声对比检测正常肝与弥漫性肝病进餐前后门静脉和右肝动脉血流改变。
Methods By using ultrasound scanner, to compare the flow changes in portal vein and right hepatic artery of diffused hepatic lesions before and after meal with that of normal liver.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis.
在发达国家，非酒精性脂肪性肝病(NAFLD)是一种很常见的慢性肝脏疾病。
Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in affluent countries.
临床上分为酒精性肝病（ALD）和非酒精性脂肪性肝病（NAFLD）两大类。
The FLD includes alcohol-induced liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD).
现代医学已经对它进行了比较深入的研究，但至今仍未找到脂肪性肝病的特效治疗药物。
Western Medicine has already carried on an in-depth study on it, but has not find out the miracle drug as yet.
应用推荐